Daiichi Sankyo Appoints New Translational Research Chief as Veteran Retires
Event summary
- Veronika Rozehnal, Ph.D., has been appointed Head of Daiichi Sankyo Translational Research Center Europe, succeeding Jürgen Müller, Ph.D.
- Jürgen Müller is retiring after nearly 30 years with Daiichi Sankyo.
- The Translational Research Center Europe, founded in 1997, has grown from 3 to 40 researchers under Müller's leadership.
- Veronika Rozehnal previously held various roles at the Translational Research Center Europe and spent three years at the Daiichi Sankyo R&D Center in Tokyo.
The big picture
The leadership change at the Translational Research Center Europe highlights the ongoing evolution of Daiichi Sankyo's R&D strategy, emphasizing a global approach to drug discovery. The center’s growth under Müller demonstrates the importance of European research to the company’s innovation pipeline, and Rozehnal’s appointment signals a continued commitment to this region. The retirement of a long-standing executive often precedes shifts in operational priorities and resource allocation, which could impact the center's focus.
What we're watching
- Leadership Transition
- Rozehnal’s experience in both Europe and Tokyo suggests a focus on integrating global research efforts, but the speed of that integration remains to be seen.
- R&D Strategy
- Müller’s departure marks a shift in leadership at a key R&D hub; the center’s strategic direction and project prioritization under Rozehnal will be crucial to Daiichi Sankyo’s future pipeline.
- European Presence
- Daiichi Sankyo’s commitment to expanding its European research footprint will be tested by Rozehnal’s ability to maintain the center’s reputation for scientific excellence and attract top talent.
Related topics